Put Options

17 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$51.3 - $64.42 $543,780 - $682,852
10,600 New
10,600 $606,000
Q3 2023

Nov 14, 2023

BUY
$36.46 - $44.03 $109,380 - $132,090
3,000 New
3,000 $114,000
Q4 2022

Feb 14, 2023

BUY
$40.06 - $59.44 $1.63 Million - $2.42 Million
40,700 Added 339.17%
52,700 $3 Million
Q3 2022

Nov 14, 2022

BUY
$38.53 - $51.78 $362,182 - $486,732
9,400 Added 361.54%
12,000 $474,000
Q2 2022

Aug 08, 2022

BUY
$37.35 - $48.3 $7,470 - $9,660
200 Added 8.33%
2,600 $114,000
Q1 2022

May 16, 2022

SELL
$31.97 - $41.06 $134,274 - $172,452
-4,200 Reduced 63.64%
2,400 $96,000
Q4 2021

Feb 14, 2022

BUY
$31.82 - $40.75 $136,826 - $175,225
4,300 Added 186.96%
6,600 $265,000
Q3 2021

Nov 15, 2021

BUY
$38.47 - $46.42 $88,481 - $106,766
2,300 New
2,300 $94,000
Q2 2021

Aug 16, 2021

SELL
$38.84 - $51.31 $462,196 - $610,589
-11,900 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$39.51 - $51.45 $142,236 - $185,220
-3,600 Reduced 23.23%
11,900 $496,000
Q4 2020

Feb 16, 2021

BUY
$25.81 - $43.62 $56,782 - $95,964
2,200 Added 16.54%
15,500 $662,000
Q3 2020

Nov 16, 2020

SELL
$25.74 - $29.63 $157,014 - $180,743
-6,100 Reduced 31.44%
13,300 $350,000
Q1 2020

May 15, 2020

BUY
$13.9 - $21.83 $266,880 - $419,135
19,200 Added 9600.0%
19,400 $349,000
Q4 2019

Feb 14, 2020

SELL
$14.93 - $19.53 $134,370 - $175,770
-9,000 Reduced 97.83%
200 $4,000
Q3 2019

Nov 14, 2019

BUY
$15.2 - $17.69 $86,640 - $100,833
5,700 Added 162.86%
9,200 $143,000
Q2 2019

Aug 14, 2019

SELL
$14.75 - $17.26 $172,575 - $201,942
-11,700 Reduced 76.97%
3,500 $60,000
Q2 2018

Aug 14, 2018

BUY
$16.87 - $20.3 $256,424 - $308,560
15,200 New
15,200 $256,000

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.57B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.